Newcastle Disease Vaccine Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: N7E3CDC6F6C9EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Newcastle Disease Vaccine in global, including the following market information:

Global Newcastle Disease Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Newcastle Disease Vaccine Market Sales, 2016-2021, 2022-2027, (M Doses)

Global top five Newcastle Disease Vaccine companies in 2020 (%)

The global Newcastle Disease Vaccine market was valued at 313.7 million in 2020 and is projected to reach US$ 355.2 million by 2027, at a CAGR of 3.1% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newcastle Disease Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Newcastle Disease Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Newcastle Disease Vaccine Market Segment Percentages, By Type, 2020 (%)

• Live Vaccines
• Killed Vaccines

Global Newcastle Disease Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Newcastle Disease Vaccine Market Segment Percentages, By Application, 2020 (%)

• Chicken
• Duck & Goose
• Other

Global Newcastle Disease Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

Global Newcastle Disease Vaccine Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Newcastle Disease Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Newcastle Disease Vaccine revenues share in global market, 2020 (%)

Key companies Newcastle Disease Vaccine sales in global market, 2016-2021 (Estimated), (M Doses)

Key companies Newcastle Disease Vaccine sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merial
• CEVA
• QYH Biotech
• Ringpu Biology
• Yebio
• Harbin Veterinary Research Institute
• Merck Animal Health
• DHN
• Zoetis
• ChengDu Tecbond
• Elanco (Lohmann)
• FATRO
• CAVAC
• Vaksindo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Newcastle Disease Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Newcastle Disease Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEWCASTLE DISEASE VACCINE OVERALL MARKET SIZE

2.1 Global Newcastle Disease Vaccine Market Size: 2021 VS 2027
2.2 Global Newcastle Disease Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Newcastle Disease Vaccine Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Newcastle Disease Vaccine Players in Global Market
3.2 Top Global Newcastle Disease Vaccine Companies Ranked by Revenue
3.3 Global Newcastle Disease Vaccine Revenue by Companies
3.4 Global Newcastle Disease Vaccine Sales by Companies
3.5 Global Newcastle Disease Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Newcastle Disease Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Newcastle Disease Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Newcastle Disease Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Newcastle Disease Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Newcastle Disease Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Newcastle Disease Vaccine Market Size Markets, 2021 & 2027
  4.1.2 Live Vaccines
  4.1.3 Killed Vaccines
4.2 By Type - Global Newcastle Disease Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Newcastle Disease Vaccine Revenue, 2016-2021
  4.2.2 By Type - Global Newcastle Disease Vaccine Revenue, 2022-2027
  4.2.3 By Type - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Newcastle Disease Vaccine Sales & Forecasts
  4.3.1 By Type - Global Newcastle Disease Vaccine Sales, 2016-2021
  4.3.2 By Type - Global Newcastle Disease Vaccine Sales, 2022-2027
  4.3.3 By Type - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Newcastle Disease Vaccine Market Size, 2021 & 2027
  5.1.2 Chicken
  5.1.3 Duck & Goose
  5.1.4 Other
5.2 By Application - Global Newcastle Disease Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Newcastle Disease Vaccine Revenue, 2016-2021
  5.2.2 By Application - Global Newcastle Disease Vaccine Revenue, 2022-2027
  5.2.3 By Application - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Newcastle Disease Vaccine Sales & Forecasts
  5.3.1 By Application - Global Newcastle Disease Vaccine Sales, 2016-2021
  5.3.2 By Application - Global Newcastle Disease Vaccine Sales, 2022-2027
  5.3.3 By Application - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Newcastle Disease Vaccine Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Newcastle Disease Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Newcastle Disease Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Newcastle Disease Vaccine Revenue, 2016-2021
  6.2.2 By Region - Global Newcastle Disease Vaccine Revenue, 2022-2027
  6.2.3 By Region - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Newcastle Disease Vaccine Sales & Forecasts
  6.3.1 By Region - Global Newcastle Disease Vaccine Sales, 2016-2021
  6.3.2 By Region - Global Newcastle Disease Vaccine Sales, 2022-2027
  6.3.3 By Region - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Newcastle Disease Vaccine Revenue, 2016-2027
  6.4.2 By Country - North America Newcastle Disease Vaccine Sales, 2016-2027
  6.4.3 US Newcastle Disease Vaccine Market Size, 2016-2027
  6.4.4 Canada Newcastle Disease Vaccine Market Size, 2016-2027
  6.4.5 Mexico Newcastle Disease Vaccine Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Newcastle Disease Vaccine Revenue, 2016-2027
  6.5.2 By Country - Europe Newcastle Disease Vaccine Sales, 2016-2027
  6.5.3 Germany Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.4 France Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.5 U.K. Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.6 Italy Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.7 Russia Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.8 Nordic Countries Newcastle Disease Vaccine Market Size, 2016-2027
  6.5.9 Benelux Newcastle Disease Vaccine Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Newcastle Disease Vaccine Revenue, 2016-2027
  6.6.2 By Region - Asia Newcastle Disease Vaccine Sales, 2016-2027
  6.6.3 China Newcastle Disease Vaccine Market Size, 2016-2027
  6.6.4 Japan Newcastle Disease Vaccine Market Size, 2016-2027
  6.6.5 South Korea Newcastle Disease Vaccine Market Size, 2016-2027
  6.6.6 Southeast Asia Newcastle Disease Vaccine Market Size, 2016-2027
  6.6.7 India Newcastle Disease Vaccine Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Newcastle Disease Vaccine Revenue, 2016-2027
  6.7.2 By Country - South America Newcastle Disease Vaccine Sales, 2016-2027
  6.7.3 Brazil Newcastle Disease Vaccine Market Size, 2016-2027
  6.7.4 Argentina Newcastle Disease Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Newcastle Disease Vaccine Sales, 2016-2027
  6.8.3 Turkey Newcastle Disease Vaccine Market Size, 2016-2027
  6.8.4 Israel Newcastle Disease Vaccine Market Size, 2016-2027
  6.8.5 Saudi Arabia Newcastle Disease Vaccine Market Size, 2016-2027
  6.8.6 UAE Newcastle Disease Vaccine Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Merial
  7.1.1 Merial Corporate Summary
  7.1.2 Merial Business Overview
  7.1.3 Merial Newcastle Disease Vaccine Major Product Offerings
  7.1.4 Merial Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.1.5 Merial Key News
7.2 CEVA
  7.2.1 CEVA Corporate Summary
  7.2.2 CEVA Business Overview
  7.2.3 CEVA Newcastle Disease Vaccine Major Product Offerings
  7.2.4 CEVA Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.2.5 CEVA Key News
7.3 QYH Biotech
  7.3.1 QYH Biotech Corporate Summary
  7.3.2 QYH Biotech Business Overview
  7.3.3 QYH Biotech Newcastle Disease Vaccine Major Product Offerings
  7.3.4 QYH Biotech Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.3.5 QYH Biotech Key News
7.4 Ringpu Biology
  7.4.1 Ringpu Biology Corporate Summary
  7.4.2 Ringpu Biology Business Overview
  7.4.3 Ringpu Biology Newcastle Disease Vaccine Major Product Offerings
  7.4.4 Ringpu Biology Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.4.5 Ringpu Biology Key News
7.5 Yebio
  7.5.1 Yebio Corporate Summary
  7.5.2 Yebio Business Overview
  7.5.3 Yebio Newcastle Disease Vaccine Major Product Offerings
  7.5.4 Yebio Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.5.5 Yebio Key News
7.6 Harbin Veterinary Research Institute
  7.6.1 Harbin Veterinary Research Institute Corporate Summary
  7.6.2 Harbin Veterinary Research Institute Business Overview
  7.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Major Product Offerings
  7.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.6.5 Harbin Veterinary Research Institute Key News
7.7 Merck Animal Health
  7.7.1 Merck Animal Health Corporate Summary
  7.7.2 Merck Animal Health Business Overview
  7.7.3 Merck Animal Health Newcastle Disease Vaccine Major Product Offerings
  7.4.4 Merck Animal Health Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.7.5 Merck Animal Health Key News
7.8 DHN
  7.8.1 DHN Corporate Summary
  7.8.2 DHN Business Overview
  7.8.3 DHN Newcastle Disease Vaccine Major Product Offerings
  7.8.4 DHN Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.8.5 DHN Key News
7.9 Zoetis
  7.9.1 Zoetis Corporate Summary
  7.9.2 Zoetis Business Overview
  7.9.3 Zoetis Newcastle Disease Vaccine Major Product Offerings
  7.9.4 Zoetis Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.9.5 Zoetis Key News
7.10 ChengDu Tecbond
  7.10.1 ChengDu Tecbond Corporate Summary
  7.10.2 ChengDu Tecbond Business Overview
  7.10.3 ChengDu Tecbond Newcastle Disease Vaccine Major Product Offerings
  7.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.10.5 ChengDu Tecbond Key News
7.11 Elanco (Lohmann)
  7.11.1 Elanco (Lohmann) Corporate Summary
  7.11.2 Elanco (Lohmann) Newcastle Disease Vaccine Business Overview
  7.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Major Product Offerings
  7.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.11.5 Elanco (Lohmann) Key News
7.12 FATRO
  7.12.1 FATRO Corporate Summary
  7.12.2 FATRO Newcastle Disease Vaccine Business Overview
  7.12.3 FATRO Newcastle Disease Vaccine Major Product Offerings
  7.12.4 FATRO Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.12.5 FATRO Key News
7.13 CAVAC
  7.13.1 CAVAC Corporate Summary
  7.13.2 CAVAC Newcastle Disease Vaccine Business Overview
  7.13.3 CAVAC Newcastle Disease Vaccine Major Product Offerings
  7.13.4 CAVAC Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.13.5 CAVAC Key News
7.14 Vaksindo
  7.14.1 Vaksindo Corporate Summary
  7.14.2 Vaksindo Business Overview
  7.14.3 Vaksindo Newcastle Disease Vaccine Major Product Offerings
  7.14.4 Vaksindo Newcastle Disease Vaccine Sales and Revenue in Global (2016-2021)
  7.14.5 Vaksindo Key News

8 GLOBAL NEWCASTLE DISEASE VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Newcastle Disease Vaccine Production Capacity, 2016-2027
8.2 Newcastle Disease Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Newcastle Disease Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 NEWCASTLE DISEASE VACCINE SUPPLY CHAIN ANALYSIS

10.1 Newcastle Disease Vaccine Industry Value Chain
10.2 Newcastle Disease Vaccine Upstream Market
10.3 Newcastle Disease Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Newcastle Disease Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Newcastle Disease Vaccine in Global Market
Table 2. Top Newcastle Disease Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Newcastle Disease Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Newcastle Disease Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Newcastle Disease Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. Global Newcastle Disease Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Newcastle Disease Vaccine Price (2016-2021) & (USD/K Doses)
Table 8. Global Manufacturers Newcastle Disease Vaccine Product Type
Table 9. List of Global Tier 1 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Newcastle Disease Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Newcastle Disease Vaccine Sales (M Doses), 2016-2021
Table 15. By Type - Global Newcastle Disease Vaccine Sales (M Doses), 2022-2027
Table 16. By Application – Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Newcastle Disease Vaccine Sales (M Doses), 2016-2021
Table 20. By Application - Global Newcastle Disease Vaccine Sales (M Doses), 2022-2027
Table 21. By Region – Global Newcastle Disease Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Newcastle Disease Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Newcastle Disease Vaccine Sales (M Doses), 2016-2021
Table 25. By Region - Global Newcastle Disease Vaccine Sales (M Doses), 2022-2027
Table 26. By Country - North America Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Newcastle Disease Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Newcastle Disease Vaccine Sales, (M Doses), 2016-2021
Table 29. By Country - North America Newcastle Disease Vaccine Sales, (M Doses), 2022-2027
Table 30. By Country - Europe Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Newcastle Disease Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Newcastle Disease Vaccine Sales, (M Doses), 2016-2021
Table 33. By Country - Europe Newcastle Disease Vaccine Sales, (M Doses), 2022-2027
Table 34. By Region - Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Newcastle Disease Vaccine Sales, (M Doses), 2016-2021
Table 37. By Region - Asia Newcastle Disease Vaccine Sales, (M Doses), 2022-2027
Table 38. By Country - South America Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Newcastle Disease Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Newcastle Disease Vaccine Sales, (M Doses), 2016-2021
Table 41. By Country - South America Newcastle Disease Vaccine Sales, (M Doses), 2022-2027
Table 42. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Newcastle Disease Vaccine Sales, (M Doses), 2016-2021
Table 45. By Country - Middle East & Africa Newcastle Disease Vaccine Sales, (M Doses), 2022-2027
Table 46. Merial Corporate Summary
Table 47. Merial Newcastle Disease Vaccine Product Offerings
Table 48. Merial Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 49. CEVA Corporate Summary
Table 50. CEVA Newcastle Disease Vaccine Product Offerings
Table 51. CEVA Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 52. QYH Biotech Corporate Summary
Table 53. QYH Biotech Newcastle Disease Vaccine Product Offerings
Table 54. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 55. Ringpu Biology Corporate Summary
Table 56. Ringpu Biology Newcastle Disease Vaccine Product Offerings
Table 57. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 58. Yebio Corporate Summary
Table 59. Yebio Newcastle Disease Vaccine Product Offerings
Table 60. Yebio Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 61. Harbin Veterinary Research Institute Corporate Summary
Table 62. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product Offerings
Table 63. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 64. Merck Animal Health Corporate Summary
Table 65. Merck Animal Health Newcastle Disease Vaccine Product Offerings
Table 66. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 67. DHN Corporate Summary
Table 68. DHN Newcastle Disease Vaccine Product Offerings
Table 69. DHN Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 70. Zoetis Corporate Summary
Table 71. Zoetis Newcastle Disease Vaccine Product Offerings
Table 72. Zoetis Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 73. ChengDu Tecbond Corporate Summary
Table 74. ChengDu Tecbond Newcastle Disease Vaccine Product Offerings
Table 75. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 76. Elanco (Lohmann) Corporate Summary
Table 77. Elanco (Lohmann) Newcastle Disease Vaccine Product Offerings
Table 78. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 79. FATRO Corporate Summary
Table 80. FATRO Newcastle Disease Vaccine Product Offerings
Table 81. FATRO Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 82. CAVAC Corporate Summary
Table 83. CAVAC Newcastle Disease Vaccine Product Offerings
Table 84. CAVAC Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 85. Vaksindo Corporate Summary
Table 86. Vaksindo Newcastle Disease Vaccine Product Offerings
Table 87. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/K Doses) (2016-2021)
Table 88. Newcastle Disease Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2019-2021 (M Doses)
Table 89. Global Newcastle Disease Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 90. Global Newcastle Disease Vaccine Production by Region, 2016-2021 (M Doses)
Table 91. Global Newcastle Disease Vaccine Production by Region, 2022-2027 (M Doses)
Table 92. Newcastle Disease Vaccine Market Opportunities & Trends in Global Market
Table 93. Newcastle Disease Vaccine Market Drivers in Global Market
Table 94. Newcastle Disease Vaccine Market Restraints in Global Market
Table 95. Newcastle Disease Vaccine Raw Materials
Table 96. Newcastle Disease Vaccine Raw Materials Suppliers in Global Market
Table 97. Typical Newcastle Disease Vaccine Downstream
Table 98. Newcastle Disease Vaccine Downstream Clients in Global Market
Table 99. Newcastle Disease Vaccine Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Newcastle Disease Vaccine Segment by Type
Figure 2. Newcastle Disease Vaccine Segment by Application
Figure 3. Global Newcastle Disease Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Newcastle Disease Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Newcastle Disease Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Newcastle Disease Vaccine Sales in Global Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Newcastle Disease Vaccine Revenue in 2020
Figure 9. By Type - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global Newcastle Disease Vaccine Price (USD/K Doses), 2016-2027
Figure 12. By Application - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global Newcastle Disease Vaccine Price (USD/K Doses), 2016-2027
Figure 15. By Region - Global Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 19. US Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 24. Germany Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 33. China Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Newcastle Disease Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Newcastle Disease Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Newcastle Disease Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global Newcastle Disease Vaccine Production Capacity (M Doses), 2016-2027
Figure 49. The Percentage of Production Newcastle Disease Vaccine by Region, 2020 VS 2027
Figure 50. Newcastle Disease Vaccine Industry Value Chain
Figure 51. Marketing Channels